In one example, this generated a truncated version of the estrogen receptor gene ESR1. Recently, it has been reported that fusion transcripts arising from breaks in the same intron of ESR1 are recurrent in breast cancer and can confer resistance to endocrine therapy (Li et al., 2013). Here, ESR1 is linked to breast cancer.